Radiosensitivity of squamous cell carcinoma metastases to the neck assessed by immunocytochemical profiling of fine-needle aspiration biopsy cell specimens: A pilot study

Radiotherapy and Oncology

Volumn 93, Issue 3, 2009, Pages 575-580

  Fležar, Margareta Strojan ^a   Kirbiš, Irena Srebotnik ^a   Popović, Katarina Šurlan ^b   Strojan, Primož ^c  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Fine needle aspiration biopsy; Head and neck cancer; Immunocytochemistry; Prognosis; Radiosensitivity

Indexed keywords

CISPLATIN; CYCLIN D1; KI 67 ANTIGEN; MITOMYCIN C; PROTEIN P53; STEFIN A;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE ESCALATION; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; HYPOPHARYNX CANCER; LARYNX CANCER; MALE; NECK METASTASIS; OROPHARYNX CANCER; PRIORITY JOURNAL; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; BIOPSY, FINE-NEEDLE; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; CYSTATIN A; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; RADIATION TOLERANCE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70449686564     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.09.007     Document Type: Article

References (33)

1. Bataini J.P., Bernier J., Asselain B., et al. Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: tentative multivariate modelling system to predict the radiocurability of neck nodes. Int J Radiat Oncol Biol Phys 14 (1988) 635-642
2. Mack M.G., Rieger J., Baghi M., Bisdas S., and Vogl T.J. Cervical lymph nodes. Eur J Radiol 66 (2008) 493-500
3. Vergeer M.R., Doornaert P., Leemans C.R., Buter J., Slotman B.J., and Langendijk J.A. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation. Radiother Oncol 79 (2006) 39-44
4. 18F]-misonidasole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group study 98.02. J Clin Oncol 24 (2006) 2098-2104
5. Corry J., Smith J.G., and Peters L.J. The concept of a planned neck dissection is obsolete. Cancer J 7 (2001) 472-474
6. Giardini R., Martelli G., Rilke F., and Pilotta S. Diagnostic problems of second primary malignancies detected by fine-needle aspiration cytology. Cancer 72 (1993) 2716-2722
7. Raybaud-Diogène H., Fortin A., Morency R., Roy J., Monteil R.A., and Têtu B. Markers of radioresistance in squamous cell carcinoma of the head and neck: a clinicopathologic and immunohistochemical study. J Clin Oncol 15 (1997) 1030-1038
8. Couture C., Raybaud-Diogène H., Têtu B., et al. P53 and Ki-67 as markers of radioresistance in head and neck carcinoma. Cancer 94 (2001) 713-722
9. Buffa F.M., Bentzen S.M., Daley F.M., et al. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy. Clin Cancer Res 10 (2004) 3745-3754
10. Trent S., Yang C., Li C., Lynch M., and Schmidt E.V. Heat shock protein B8, a cyclin-dependent kinase-independent cyclin D1 target gene, contributes to its effects on radiation sensitivity. Cancer Res 67 (2007) 10774-10781
11. Vigneswaran N., Wu J., Nagaraj N., Adler-Storthz K., and Zacharias W. Differential susceptibility of metastatic and primary oral cancer cells to TRIAL-induced apoptosis. Int J Oncol 26 (2005) 103-112
12. Strojan P., Karner K., Šmid L., et al. Concomitant chemoradiotherapy with mitomycin C and cisplatin in advanced unresectable carcinoma of the head and neck: phase I-II clinical study. Int J Radiat Oncol Biol Phys 72 (2008) 365-372
13. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 53 (1958) 457-481
14. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35 (1977) 1-39
15. Ataman O.U., Bentzen S.M., Wilson G.D., et al. Molecular biomarkers and site of first recurrence after radiotherapy for head and neck cancer. Eur J Cancer 40 (2004) 2734-2741
16. Calgaro N., Marioni G., Blandamura S., et al. P27 and MIB-1 expression is related to malignancy recurrence in laryngeal carcinoma treated with partial laryngectomy: preliminary results. J Otolaryngol 36 (2007) 98-105
17. Roepman P., Wessels L.F.A., Kettelarij N., et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinoma. Nat Genet 37 (2005) 182-186
18. Watanabe H., Mogushi K., Miura M., et al. Prediction of lymphatic metastasis based on gene expression profile analysis after brachytherapy for early-stage oral tongue carcinoma. Radiother Oncol 87 (2008) 237-242
19. Benzen S.M., Johansen L.V., Overgaard J., and Thames H.D. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 20 (1991) 1197-1206
20. Joyce J.A., and Pollard J.W. Microenvironmental regulation of metastasis. Nat Rev Cancer 9 (2009) 239-252
21. Cabanillas R., Rodrigo J.P., Astudillo A., Domínguez F., Suárez C., and Chiara M.D. P53 expression in squamous cell carcinoma of the supraglottic larynx and its lymph node metastases: new results for an old question. Cancer 109 (2007) 1791-1798
22. Strojan P., Oblak I., Gale N., Šmid L., and Kos J. Cysteine cathepsins B and L and their inhibitors stefins A and B in carcinoma of the oropharynx: immunohistochemical study. Histopathology 53 (2008) 612-614
23. Caraway N.P. Strategies to diagnose lymphoproliferative disorders by fine-needle aspiration by using ancillary studies. Cancer Cytopathol 105 (2005) 432-442
24. Park K., and Han S. Cytologic evaluation p53, cyclin D1, and cathepsin D and their correlation with histologic sections in primary breast carcinoma. J Korean Breast Cancer Soc 5 (2002) 113-117
25. Park K., Han S., Kim H.-Y., and Ko I. Cytologic evaluation of cyclin D1 expression in primary breast carcinoma. Cancer Cytopathol 93 (2001) 211-215
26. Binks S., Clelland C.A., Ronan J., and Bell J. P53 gene product expression in resected non-small cell carcinoma of the lung, with studies of concurrent cytological preparations and microwave antigen retrieval. J Clin Pathol 50 (1997) 320-323
27. Dowell S.P., Wilson P.O.G., Derias N.W., Lane D.P., and Hall P.A. Clinical utility of the immunocytochemical detection of 53 protein in cytological specimens. Cancer Res 54 (1994) 2914-2918
28. Sato Y., Itoh F., Hareyama M., et al. Association of cyclin D1 expression with factors correlated with tumor progression in human hepatocellular carcinoma. J Gastroenterol 34 (1999) 486-493
29. Tut V.M., Braithwaite K.L., Angus B., Neal D.E., Lunec J., and Mellon J.K. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Br J Cancer 82 (2001) 270-275
30. Pfeiffer J., Kayser G., Technau-Ihling K., Boedeker C.C., and Ridder G.J. Ultrasound-guided core-needle biopsy in the diagnosis of head and neck masses: indications, technique, and results. Head Neck 29 (2007) 1033-1040
31. Pfeiffer J., Kayser L., and Ridder G.J. Minimal-invasive core needle biopsy of head and neck malignancies: clinical evaluation for radiation oncology. Radiother Oncol 90 (2009) 202-207
32. Layfield L.J. Fine-needle aspiration in the diagnosis of head and neck lesions: a review and discussion of problems in differential diagnosis. Diagn Cytopathol 35 (2007) 798-805
33. Yip H.T., Chopra R., Chakrabarti R., et al. Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53. Arch Otolaryngol Head Neck Surg 132 (2006) 317-326